Literature DB >> 34160645

[Lymphoma in children and adolescents].

Ina Sorge1, Thomas Walter Georgi2, Franz Wolfgang Hirsch3.   

Abstract

CLINICAL/METHODOLOGICAL ISSUE: Lymphoma is the third most common neoplasm in children. Detection, accurate staging, and restaging are important for all radiologists involved in the diagnosis of children. STANDARD RADIOLOGICAL
METHODS: Magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT), CT, ultrasound, X‑ray. METHODOLOGICAL INNOVATIONS: Whole-body imaging (MRI and PET-MRI or PET-CT) play a key role in diagnostics and for therapy selection in Hodgkin lymphoma. PERFORMANCE: In particular, hybrid imaging using 18F‑FDG PET is proving to be a powerful method for staging and restaging. ACHIEVEMENTS: Standardization of imaging and inclusion in therapy studies (e.g. within the framework of the EuroNet-PHL-C2 study) improves diagnostics and simultaneously reduces therapy-related side effects. PRACTICAL RECOMMENDATIONS: In Hodgkin lymphoma, deviations from the prescribed diagnostic procedure should be avoided. In clinically very heterogeneous non-Hodgkin lymphoma (NHL), on the other hand, the diagnostic procedure should be adapted to the actual clinical condition of the child. The role of interim PET in NHL is currently still the subject of clinical discussion.

Entities:  

Keywords:  Hodgkin lymphoma; Neoplasm staging; Non-Hodgkin lymphoma; Pediatric cancer; Whole body imaging

Mesh:

Substances:

Year:  2021        PMID: 34160645     DOI: 10.1007/s00117-021-00873-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  25 in total

1.  Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial.

Authors:  Christian Furth; Ingo G Steffen; Holger Amthauer; Juri Ruf; Daniel Misch; Stefan Schönberger; Carsten Kobe; Timm Denecke; Brigitte Stöver; Hubertus Hautzel; Günter Henze; Patrick Hundsdoerfer
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

Review 2.  Extranodal Hodgkin disease: spectrum of disease.

Authors:  A Guermazi; P Brice; E de Kerviler E; C Fermé; C Hennequin; V Meignin; J Frija
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

3.  Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.

Authors:  Jamie E Flerlage; Kara M Kelly; Auke Beishuizen; Steve Cho; Pedro A De Alarcon; Ute Dieckmann; Richard A Drachtman; Bradford S Hoppe; Scott C Howard; Sue C Kaste; Regine Kluge; Lars Kurch; Judith Landman-Parker; Jocelyn Lewis; Michael P Link; Kathleen McCarten; Angela Punnett; Dietrich Stoevesandt; Stephan D Voss; William Hamish Wallace; Christine Mauz-Körholz; Monika L Metzger
Journal:  Pediatr Blood Cancer       Date:  2017-01-18       Impact factor: 3.167

4.  Distribution of ABO blood groups in childhood acute leukemia.

Authors:  Samin Alavi; Haleh Ashraf; Armin Rashidi; Negin Hosseini; Mehdi Abouzari; Mehdi Naderifar
Journal:  Pediatr Hematol Oncol       Date:  2006-12       Impact factor: 1.969

5.  All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting.

Authors:  Sally F Barrington; Tom Sulkin; Adam Forbes; Peter W M Johnson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-02       Impact factor: 9.236

6.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

7.  Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses.

Authors:  Doralina L Anghelescu; Laura L Burgoyne; Tiebin Liu; Chin-Shang Li; Ching-Hon Pui; Melissa M Hudson; Wayne L Furman; John T Sandlund
Journal:  Paediatr Anaesth       Date:  2007-11       Impact factor: 2.556

Review 8.  Cross-sectional evaluation of thoracic lymphoma.

Authors:  Young A Bae; Kyung Soo Lee
Journal:  Radiol Clin North Am       Date:  2008-03       Impact factor: 2.303

9.  Gadolinium-enhanced imaging of pediatric thoracic lymphoma: is intravenous contrast really necessary?

Authors:  Christophe T Arendt; Martin Beeres; Doris Leithner; Patricia Tischendorf; Marcel Langenbach; Benjamin Kaltenbach; Jasmin Dalgicdir; Thomas J Vogl; Tatjana Gruber-Rouh
Journal:  Eur Radiol       Date:  2018-12-13       Impact factor: 5.315

10.  Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.

Authors:  Ken Herrmann; Marcelo Queiroz; Martin W Huellner; Felipe de Galiza Barbosa; Andreas Buck; Niklaus Schaefer; Paul Stolzman; Patrick Veit-Haibach
Journal:  BMC Cancer       Date:  2015-12-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.